Prescription Drugs Market (By Product Type: Generics, Orphan, Prescription Drugs; By Therapy: Oncology, Anti-diabetics, Vaccines, Sensory organs, Immunosuppressant’s, Anticoagulants, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. Industry Overview of Prescription Drugs
1.1. Definition and Scope 
1.1.1. Definition of Prescription Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Prescription Drugs Market
1.2. Summary
1.2.1. Executive Summary 
1.2.2. Prescription Drugs Market By Product Type
1.2.3. Prescription Drugs Market By Therapy
1.2.4. Prescription Drugs Market By Distribution Channel
1.2.5. Prescription Drugs Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology 
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2 
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Prescription Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Prescription Drugs Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers 
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Prescription Drugs Major Manufacturers in 2019

CHAPTER 5. Prescription Drugs Market By Product Type
5.1. Introduction
5.2. Prescription Drugs Revenue By Product Type
5.2.1. Prescription Drugs Revenue (US$ Mn) and Forecast, By Product Type, 2016-2027
5.2.2. Generics
5.2.2.1. Generics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Orphan
5.2.3.1. Orphan Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Prescription Drugs
5.2.4.1. Prescription Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Prescription Drugs Market Revenue By Therapy
6.1. Introduction
6.2. Prescription Drugs Revenue (US$ Mn) By Therapy
6.2.1. Prescription Drugs Revenue (US$ Mn) and Forecast By Therapy, 2016 - 2027
6.2.2. Oncology
6.2.2.1. Oncology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Anti-diabetics
6.2.3.1. Anti-diabetics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Vaccines
6.2.4.1. Vaccines Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Sensory organs
6.2.5.1. Sensory organs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.6. Immunosuppressant’s
6.2.6.1. Immunosuppressant’s  Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.7. Anticoagulants
6.2.7.1. Anticoagulants Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.8. Others
6.2.8.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. Prescription Drugs Market By Distribution Channel 
7.1. Introduction
7.2. Prescription Drugs Revenue (US$ Mn) By Distribution Channel
7.2.1. Prescription Drugs Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
7.2.2. Hospital Pharmacies
7.2.2.1. Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Retail Pharmacies & Drug Stores
7.2.3.1. Retail Pharmacies & Drug Stores Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.4. Online Pharmacies
7.2.4.1. Online Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 8. North America Prescription Drugs Market By Country 
8.1. North America Prescription Drugs Overview
8.2. U.S.
8.2.1. U.S. Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.2.2. U.S. Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016-2027
8.2.3. U.S. Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.3. Canada
8.3.1. Canada Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.3.2. Canada Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016-2027
8.3.3. Canada Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.4. North America PEST Analysis

CHAPTER 9. Europe Prescription Drugs Market By Country
9.1. Europe Prescription Drugs Market Overview
9.2. U.K.
9.2.1. U.K. Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
9.2.2. U.K. Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016-2027
9.2.3. U.K. Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.3. Germany
9.3.1. Germany Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
9.3.2. Germany Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016-2027
9.3.3. Germany Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.4. France 
9.4.1. France Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
9.4.2. France Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016-2027
9.4.3. France Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.5. Spain
9.5.1. Spain Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
9.5.2. Spain Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016-2027
9.5.3. Spain Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
9.6.2. Rest of Europe Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016-2027
9.6.3. Rest of Europe Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Prescription Drugs Market By Country
10.1. Asia Pacific Prescription Drugs Market Overview
10.2. China
10.2.1. China Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.2.2. China Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016 - 2027
10.2.3. China Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.3. Japan
10.3.1. Japan Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.3.2. Japan Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016 - 2027
10.3.3. Japan Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.4. India
10.4.1. India Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.4.2. India Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016 - 2027
10.4.3. India Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.5. Australia
10.5.1. Australia Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.5.2. Australia Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016 - 2027
10.5.3. Australia Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.6.2. South Korea Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016 - 2027
10.6.3. South Korea Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.7.2. Rest of Asia-Pacific Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016 - 2027
10.7.3. Rest of Asia-Pacific Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Prescription Drugs Market By Country
11.1. Latin America Prescription Drugs Market Overview
11.2. Brazil
11.2.1. Brazil Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.2.2. Brazil Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016 - 2027
11.2.3. Brazil Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.3.2. Mexico Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016 - 2027
11.3.3. Mexico Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.4.2. Rest of Latin America Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016 – 2027
11.4.3. Rest of Latin America Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027

CHAPTER 12. Middle East & Africa Prescription Drugs Market By Country 
12.1. Middle East & Africa Prescription Drugs Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
12.2.2. Saudi Arabia Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016 - 2027
12.2.3. Saudi Arabia Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
12.3. UAE
12.3.1. UAE Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
12.3.2. UAE Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016 - 2027
12.3.3. UAE Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Prescription Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
12.4.2. Rest of Middle East & Africa Prescription Drugs Market Revenue (US$ Mn) and Forecast By Therapy, 2016 - 2027
12.4.3. Rest of Middle East & Africa Prescription Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027

CHAPTER 13. Player Analysis Of Prescription Drugs
13.1. Prescription Drugs Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Prescription Drugs Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. COMPANY PROFILE
14.1. Novartis AG
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Novartis AG 2019 Prescription Drugs Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Novartis AG
14.3. Pfizer Inc.
14.4. F.Hoffmann-La Roche Ltd
14.5. Sanofi
14.6. Johnson & Johnson Services, Inc.
14.7. Merck & CO., Inc.
14.8. Abbvie, Inc.
14.9. Astrazeneca
14.10. Others

Cart Summary